Gastric adenocarcinoma Trials in Nashville, United States
Conditions / Gastric adenocarcinoma / Nashville, United States
Gastric adenocarcinoma has been the subject of sustained clinical investigation across multiple research sites.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01631552 | Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer | COMPLETED | PHASE1/PHASE2 |
| NCT04032704 | A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors | TERMINATED | PHASE2 |
| NCT03221400 | PEN-866 in Patients With Advanced Solid Malignancies | UNKNOWN | PHASE1/PHASE2 |
| NCT04060342 | GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma | TERMINATED | PHASE1 |
| NCT05002127 | A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06) | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT03894618 | SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas | COMPLETED | PHASE1 |
| NCT07182149 | A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors | RECRUITING | PHASE1 |
| NCT04344795 | Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors | COMPLETED | PHASE1 |
| NCT02545504 | Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | COMPLETED | PHASE3 |
| NCT03809624 | Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer | TERMINATED | PHASE1 |